JIANGSU CANOPUS WISDOM MEDICAL TECHNOLOGY CO.,LTD. Financials Jiangsu Canopus Wisdom Medical Technology Co.,Ltd.
Equities
301290
CNE1000065F2
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.23 CNY | -0.63% |
|
-3.77% | -19.43% |
Valuation
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 3,749 | 2,764 |
| Enterprise Value (EV) 1 | 2,520 | 1,523 |
| P/E ratio | 28.1 x | 28.4 x |
| Yield | 1.34% | 2.17% |
| Capitalization / Revenue | 8.48 x | 6.37 x |
| EV / Revenue | 5.7 x | 3.51 x |
| EV / EBITDA | 17.9 x | 14.1 x |
| EV / FCF | 192 x | -76.3 x |
| FCF Yield | 0.52% | -1.31% |
| Price to Book | 1.71 x | 1.23 x |
| Nbr of stocks (in thousands) | 100,173 | 100,173 |
| Reference price 2 | 37.43 | 27.59 |
| Announcement Date | 4/24/23 | 4/21/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 259.3 | 295.6 | 374.4 | 446.5 | 442.1 | 433.7 |
| EBITDA 1 | 69.16 | 68.25 | 117.1 | 150.6 | 140.8 | 107.7 |
| EBIT 1 | 62.75 | 60.02 | 93.82 | 123 | 106.9 | 70.49 |
| Operating Margin | 24.2% | 20.3% | 25.06% | 27.55% | 24.19% | 16.25% |
| Earnings before Tax (EBT) 1 | 63.4 | 60.91 | 95.63 | 129.9 | 119.8 | 117.1 |
| Net income 1 | 49.71 | 48.43 | 79.7 | 110.3 | 102.5 | 97.22 |
| Net margin | 19.17% | 16.38% | 21.29% | 24.69% | 23.19% | 22.42% |
| EPS 2 | 1.020 | 0.8900 | 1.170 | 1.470 | 1.330 | 0.9700 |
| Free Cash Flow 1 | 104.2 | 84.1 | -131.5 | -2.491 | 13.16 | -19.96 |
| FCF margin | 40.2% | 28.45% | -35.13% | -0.56% | 2.98% | -4.6% |
| FCF Conversion (EBITDA) | 150.68% | 123.23% | - | - | 9.35% | - |
| FCF Conversion (Net income) | 209.64% | 173.64% | - | - | 12.84% | - |
| Dividend per Share | - | - | - | - | 0.5000 | 0.6000 |
| Announcement Date | 3/18/19 | 4/14/20 | 6/29/21 | 4/24/23 | 4/24/23 | 4/21/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 12.5 | 35 | 170 | 193 | 1,229 | 1,241 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 104 | 84.1 | -132 | -2.49 | 13.2 | -20 |
| ROE (net income / shareholders' equity) | 22% | 10.2% | 9.84% | 10.7% | 6.28% | 4.49% |
| ROA (Net income/ Total Assets) | 9.77% | 4.73% | 5.42% | 6.45% | 3.68% | 1.84% |
| Assets 1 | 509 | 1,024 | 1,472 | 1,710 | 2,782 | 5,271 |
| Book Value Per Share 2 | 6.310 | 9.850 | 13.00 | 14.50 | 21.90 | 22.30 |
| Cash Flow per Share 2 | 1.140 | 0.7400 | 1.620 | 1.840 | 11.10 | 5.680 |
| Capex 1 | 2.6 | 17.7 | 25.4 | 95.7 | 74.4 | 111 |
| Capex / Sales | 1% | 5.98% | 6.79% | 21.43% | 16.82% | 25.7% |
| Announcement Date | 3/18/19 | 4/14/20 | 6/29/21 | 4/24/23 | 4/24/23 | 4/21/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -19.43% | 305M | |
| +8.68% | 27.43B | |
| -29.70% | 3.14B | |
| +41.48% | 2.77B | |
| -18.39% | 2.46B | |
| +12.41% | 2.36B | |
| +40.00% | 2.14B | |
| -1.23% | 2.09B | |
| +48.11% | 1.49B | |
| +3.80% | 1.37B |
- Stock Market
- Equities
- 301290 Stock
- Financials Jiangsu Canopus Wisdom Medical Technology Co.,Ltd.
